Journal
CELLULAR ONCOLOGY
Volume 42, Issue 2, Pages 143-155Publisher
SPRINGER
DOI: 10.1007/s13402-018-0416-2
Keywords
Mucoepidermoid carcinoma; BRD4; Epigenetic; Cancer stem cells; iBET762; Epi-drug
Categories
Funding
- Capes Foundation within the Ministry of Education, Brazil [BEX / 88881.132606/2016-01 PDSE]
- University of Michigan School of Dentistry faculty grant
- Cancer Center Support Grant [P30 CA046592]
Ask authors/readers for more resources
PurposeEmerging evidence indicates that bromodomains comprise a conserved class of epigenome readers involved in cancer development and inflammation. Bromodomains are associated with epigenetic modifications of gene transcription through interactions with lysine residues of histone tails. Particularly, the bromodomain and extra-terminal domain (BET) family member BRD4 has been found to be involved in the control over oncogenes, including c-MYC, and in the maintenance of downstream inflammatory processes. The objective of this study was to evaluate the effect of pharmacologically displacing BRD4 in mucoepidermoid carcinoma (MEC) cells.MethodsWe assessed the presence of BRD4 levels in a panel of human MEC tissue samples in conjunction with histological grading and clinical information. In vitro studies were carried out using human MEC-derived cell lines. The BET inhibitor iBET762 was administered to MEC cells to assess the impact of disrupted BRD4 signaling on colony forming capacities and cell cycle status. The activation of cellular senescence induced by iBET762 was determined by immunohistochemical staining for p16(ink4). Flow cytometry was used to identify populations of cancer stem cells in MEC-derived cell lines.ResultsWe found that primary human MECs and MEC-derived cell lines are endowed with high BRD4 expression levels compared to those in normal salivary glands. We also found that, by displacing BRD4 from chromatin using the BET inhibitor iBET762, MEC cells lose their colony forming capacities and undergo G1 cell cycle arrest and senescence. Finally, we found that targeted displacement of BRD4 from chromatin results in depletion of cancer stem cells from the overall MEC cell populations.ConclusionsOur findings indicate that bromodomain-mediated gene regulation constitutes an epigenetic mechanism that is deregulated in MEC cells and that the use of BET inhibitors may serve as a feasible therapeutic strategy to manage MECs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available